SUPERSTRING CAPITAL MANAGEMENT LP
NEW YORK, NY · CIK 1931118 · 13F filing filed 2026-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entitySUPERSTRING CAPITAL MANAGEMENT LP (US)
- Kindhedge funds, private equity, futures
- Others nearbyNew York, NY
- FamilySUPERSTRING CAPITAL MANAGEMENT LP · 2 related pages
$158.4m
reported value
+13.2% vs Q1 2026
32positions
63.8%in top 10
8 new
13 added
9 reduced
11 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| COGENT BIOSCIENCES INC COGT | $13.3m8.39% | Added +118.1k |
| AXSOME THERAPEUTICS INC AXSM | $13.2m8.33% | Added +42.7k |
| GENMAB A/S GMAB | $11.8m7.47% | Added +233.9k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $10.7m6.76% | Added +107.5k |
| TREVI THERAPEUTICS INC TRVI | $9.8m6.17% | Added +272.7k |
| REVOLUTION MEDICINES INC RVMD | $9.6m6.04% | New |
| DEFINIUM THERAPEUTICS INC DFTX | $8.9m5.59% | Reduced -163.2k |
| VIR BIOTECHNOLOGY INC VIR | $8.7m5.49% | Added +123.1k |
| IMMUNOVANT INC IMVT | $8.0m5.07% | Reduced -149.2k |
| UROGEN PHARMA LTD URGN | $7.0m4.45% | Reduced -196.1k |
| CLIMB BIO INC CLYM | $6.8m4.29% | Added +321.9k |
| ADLAI NORTYE LTD ANL | $6.4m4.01% | Added +137.6k |
| SAVARA INC SVRA | $6.0m3.80% | Reduced -608.5k |
| MAPLIGHT THERAPEUTICS INC MPLT | $4.5m2.84% | Reduced -66.7k |
| ORIC PHARMACEUTICALS INC ORIC | $4.4m2.78% | Added +290.8k |
| UNITED THERAPEUTICS CORP DEL UTHR | $3.9m2.45% | Added +2.0k |
| VAXCYTE INC PCVX | $3.9m2.45% | Reduced -43.7k |
| BEIGENE LTD ONC | $3.5m2.21% | New |
| CABALETTA BIO INC CABA | $3.5m2.20% | Added +212.4k |
| ZAI LAB LTD ZLAB | $3.0m1.87% | Reduced -120.0k |
| SIONNA THERAPEUTICS INC SION | $2.8m1.75% | Reduced -77.9k |
| BRIGHT MINDS BIOSCIENCES INC DRUG | $2.1m1.35% | Added +17.1k |
| ACLARIS THERAPEUTICS INC ACRS | $1.4m0.86% | Reduced -108.8k |
| CYBIN INC COM NEW | $1.4m0.85% | New |
| KINIKSA PHARMACEUTICALS INTL KNSA | $1.2m0.76% | New |
| ROIVANT SCIENCES LTD ROIV | $906.8k0.57% | New |
| TONIX PHARMACEUTICALS HLDG C TNXP | $812.1k0.51% | Added +108 |
| PROTARA THERAPEUTICS INC TARA | $464.0k0.29% | Unchanged |
| FAETH THERAPEUTICS INC FTH | $354.4k0.22% | New |
| BOUNDLESS BIO INC BOLD | $138.4k0.09% | New |
| BIOMEA FUSION INC BMEA | $85.3k0.05% | Unchanged |
| VYNE THERAPEUTICS INC COM | $39.9k0.03% | New |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| SUMMIT THERAPEUTICS INC SMMT | $16.9m892.9k shares |
| VERTEX PHARMACEUTICALS INC VRTX | $4.9m11.0k shares |
| IQVIA HLDGS INC IQV | $4.4m25.7k shares |
| ARVINAS INC ARVN | $3.3m312.6k shares |
| ORUKA THERAPEUTICS INC ORKA | $3.1m63.6k shares |
| TRAVERE THERAPEUTICS INC TVTX | $3.1m102.8k shares |
| PFIZER INC PFE | $2.1m74.0k shares |
| TAYSHA GENE THERAPIES INC TSHA | $1.2m258.3k shares |
| CULLINAN THERAPEUTICS INC CGEM | $845.3k59.5k shares |
| PALATIN TECHNOLOGIES INC PTN | $626.6k36.0k shares |
| CENTURY THERAPEUTICS INC IPSC | $269.6k119.3k shares |